Literature DB >> 34100141

How to get the optimal defibrillation lead parameters using myocardial perfusion scintigraphy in patients with coronary artery disease.

Tariel A Atabekov1, Roman E Batalov2, Svetlana I Sazonova3, Sergey N Krivolapov2, Mikhail S Khlynin2, Anna I Mishkina3, Konstantin V Zavadovsky3, Antonio Curnis4, Sergey V Popov2.   

Abstract

The conventional criteria for a defibrillation lead (DL) implantation don't take into account presence of scar or deep ischemia in the myocardium. This may impair a proper functioning of the DL. We sought to optimize the DL implantation placement using rest myocardial perfusion scintigraphy (MPS), which allow detecting areas of myocardial hypoperfusion (MH). To study the influence of MH and scarring, detected by MPS, on the DL parameters in patients with coronary artery disease (CAD). 69 patients (male-65, age 64.8 ± 7.7 years) with CAD and indications for ICD implantation were enrolled. Two days before ICD implantation all patients underwent MPS at rest. Then patients were divided in 2 groups. In the 1st group DL was implanted considering MPS results: to the septal position, if the most significant MH were detected in the apical segments, and to the apical position, if MH were in the septal segments. In the 2nd group DL was implanted using the conventional approach without considering MPS results. Clinical 12 months follow-up was performed with ICD interrogation. Patients of both groups were comparable by clinical and scintigraphic parameters. In the same time, in the 1st group pacing threshold was lower (p < 0.0001) and ventricle signal amplitude was higher (p < 0.0001) comparing with the 2nd group at all control points. The presence of MH detected by MPS in the area of the DL placement worsens its parameters. The results of MPS in patients with CAD can be useful for optimization of DL placement.

Entities:  

Keywords:  Implantable cardioverter-defibrillator; Myocardial perfusion scintigraphy; Pacing threshold; Ventricle signal amplitude

Year:  2021        PMID: 34100141     DOI: 10.1007/s10554-021-02308-x

Source DB:  PubMed          Journal:  Int J Cardiovasc Imaging        ISSN: 1569-5794            Impact factor:   2.357


  16 in total

1.  2015 HRS/EHRA/APHRS/SOLAECE expert consensus statement on optimal implantable cardioverter-defibrillator programming and testing.

Authors:  Bruce L Wilkoff; Laurent Fauchier; Martin K Stiles; Carlos A Morillo; Sana M Al-Khatib; Jesús Almendral; Luis Aguinaga; Ronald D Berger; Alejandro Cuesta; James P Daubert; Sergio Dubner; Kenneth A Ellenbogen; N A Mark Estes; Guilherme Fenelon; Fermin C Garcia; Maurizio Gasparini; David E Haines; Jeff S Healey; Jodie L Hurtwitz; Roberto Keegan; Christof Kolb; Karl-Heinz Kuck; Germanas Marinskis; Martino Martinelli; Mark Mcguire; Luis G Molina; Ken Okumura; Alessandro Proclemer; Andrea M Russo; Jagmeet P Singh; Charles D Swerdlow; Wee Siong Teo; William Uribe; Sami Viskin; Chun-Chieh Wang; Shu Zhang
Journal:  Europace       Date:  2015-11-19       Impact factor: 5.214

2.  Single vs. dual chamber implantable cardioverter-defibrillators or programming of implantable cardioverter-defibrillators in patients without a bradycardia pacing indication: systematic review and meta-analysis.

Authors:  Emily P Zeitler; Gillian D Sanders; Kavisha Singh; Ruth Ann Greenfield; Anne M Gillis; Bruce L Wilkoff; Jonathan P Piccini; Sana M Al-Khatib
Journal:  Europace       Date:  2018-10-01       Impact factor: 5.214

3.  Near-field impedance accurately distinguishes among pericardial, intracavitary, and anterior mediastinal position.

Authors:  David A Burkland; Anand V Ganapathy; Mathews John; Brian D Greet; Mohammad Saeed; Abdi Rasekh; Mehdi Razavi
Journal:  J Cardiovasc Electrophysiol       Date:  2017-09-15

4.  A prospective randomized trial of single- or dual-chamber implantable cardioverter-defibrillators to minimize inappropriate shock risk in primary sudden cardiac death prevention.

Authors:  Paul A Friedman; David Bradley; Celeste Koestler; Joshua Slusser; David Hodge; Kent Bailey; Fred Kusumoto; Thomas M Munger; Arie Militanu; Michael Glikson
Journal:  Europace       Date:  2014-06-13       Impact factor: 5.214

5.  Noise, artifact, and oversensing related inappropriate ICD shock evaluation: ALTITUDE noise study.

Authors:  Brian D Powell; Samuel J Asirvatham; David L Perschbacher; Paul W Jones; Yong-Mei Cha; David A Cesario; Michael Cao; F Roosevelt Gilliam; Leslie A Saxon
Journal:  Pacing Clin Electrophysiol       Date:  2012-04-22       Impact factor: 1.976

6.  Endocardial infarct scar recognition by myocardial electrical impedance is not influenced by changes in cardiac activation sequence.

Authors:  Gerard Amorós-Figueras; Esther Jorge; Concepción Alonso-Martin; Daniel Traver; Maria Ballesta; Ramon Bragós; Javier Rosell-Ferrer; Juan Cinca
Journal:  Heart Rhythm       Date:  2017-12-27       Impact factor: 6.343

7.  Pacing and implantable cardioverter defibrillator lead perforation as assessed by multiplanar reformatted ECG-gated cardiac computed tomography and clinical correlates.

Authors:  Benjamin J Pang; Elaine H Lui; Subodh B Joshi; Mark A Tacey; Jeff Alison; Sujith K Seneviratne; James D Cameron; Harry G Mond
Journal:  Pacing Clin Electrophysiol       Date:  2014-05       Impact factor: 1.976

8.  Macrophage subpopulations are essential for infarct repair with and without stem cell therapy.

Authors:  Tamar Ben-Mordechai; Radka Holbova; Natalie Landa-Rouben; Tamar Harel-Adar; Micha S Feinberg; Ihab Abd Elrahman; Galia Blum; Fred H Epstein; Zmira Silman; Smadar Cohen; Jonathan Leor
Journal:  J Am Coll Cardiol       Date:  2013-08-21       Impact factor: 24.094

9.  EANM procedural guidelines for radionuclide myocardial perfusion imaging with SPECT and SPECT/CT: 2015 revision.

Authors:  Hein J Verberne; Wanda Acampa; Constantinos Anagnostopoulos; Jim Ballinger; Frank Bengel; Pieter De Bondt; Ronny R Buechel; Alberto Cuocolo; Berthe L F van Eck-Smit; Albert Flotats; Marcus Hacker; Cecilia Hindorf; Philip A Kaufmann; Oliver Lindner; Michael Ljungberg; Markus Lonsdale; Alain Manrique; David Minarik; Arthur J H A Scholte; Riemer H J A Slart; Elin Trägårdh; Tim C de Wit; Birger Hesse
Journal:  Eur J Nucl Med Mol Imaging       Date:  2015-08-21       Impact factor: 9.236

10.  Atrial signal amplitude predicts atrial high-rate episodes in implantable cardioverter defibrillator patients: Insights from a large database of remote monitoring transmissions.

Authors:  Massimo Zecchin; Francesco Solimene; Antonio D'Onofrio; Gabriele Zanotto; Saverio Iacopino; Carlo Pignalberi; Valeria Calvi; Giampiero Maglia; Paolo Della Bella; Fabio Quartieri; Antonio Curnis; Mauro Biffi; Alessandro Capucci; Fabrizio Caravati; Gaetano Senatore; Matteo Santamaria; Fabio Lissoni; Michele Manzo; Massimiliano Marini; Massimo Giammaria; Antonio Rapacciuolo; Gianfranco Sinagra; Daniele Giacopelli; Alessio Gargaro; Ennio C Pisanò
Journal:  J Arrhythm       Date:  2020-03-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.